SMAD is a pivotal intracellular effector for TGF-β and BMP signaling (Dituri et al., 2019), both involved in the pathophysiology of psoriasis (Borek et al., 2020; Sconocchia et al., 2021). Here, TGFB1 is linked to psoriasis.